SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-20-031413
Filing Date
2020-07-01
Accepted
2020-07-01 10:01:36
Documents
12
Period of Report
2020-07-01

Document Format Files

Seq Description Document Type Size
1 6-K bntx-6k_20200701.htm 6-K 17928
2 EX-99.1 bntx-ex991_7.htm EX-99.1 40356
3 EX-99.2 bntx-ex992_34.htm EX-99.2 974025
4 GRAPHIC gplvejhb5qc5000007.jpg GRAPHIC 37462
5 GRAPHIC gkqlyuvotgwl000001.jpg GRAPHIC 6330
6 GRAPHIC gplvejhb5qc5000002.jpg GRAPHIC 19227
7 GRAPHIC gplvejhb5qc5000003.jpg GRAPHIC 20787
8 GRAPHIC gplvejhb5qc5000006.jpg GRAPHIC 20971
9 GRAPHIC gplvejhb5qc5000005.jpg GRAPHIC 25450
10 GRAPHIC gplvejhb5qc5000004.jpg GRAPHIC 19339
11 GRAPHIC gplvejhb5qc5000001.jpg GRAPHIC 32685
12 GRAPHIC gkqlyuvotgwl000002.jpg GRAPHIC 21283
  Complete submission text file 0001564590-20-031413.txt   1314915
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190847081
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 201004344
SIC: 2836 Biological Products, (No Diagnostic Substances)